We coexpressed Kaposi's sarcoma-associated herpesvirus G protein-coupled receptors (KSHV-GPCRs) with thyrotropin-releasing hormone (TRH) receptors or m1-muscarinic-cholinergic receptors in Xenopus oocytes and in mammalian cells. In oocytes, KSHV-GPCR expression resulted in pronounced (81%) inhibition (heterologous desensitization) of Ca 2؉ -activated chloride current responses to TRH and acetylcholine. 45 Ca 2؉ efflux. In KSHV-GPCR-expressing oocytes, responses to microinjected inositol 1,4,5-trisphosphate were inhibited by 74%, and this effect was partially reversed by interferon-␥-inducible protein 10. Treatment with thapsigargin suggested that the pool of calcium available for mobilization by TRH was decreased in oocytes coexpressing KSHV-GPCRs. These results suggest that constitutive signaling by KSHV-GPCR causes heterologous desensitization of responses mediated by other receptors, which signal via the phosphoinositide/calcium pathway, which is caused by depletion of intracellular calcium pools.
KSHV-GPCR,1 the gene product of ORF74 in the KSHV (human herpesvirus 8) genome, is a GPCR homologous to human chemokine CXC receptor 2 (1, 2). Our group demonstrated that rodent fibroblasts expressing KSHV-GPCRs formed tumors in mice (3). Recently, transgenic mice in which the KSHV-GPCR gene was regulated by the human CD2 enhancer/promoter and locus control region were shown to develop angioproliferative lesions that resembled the lesions of KS (4). These reports make the mechanism of action of KSHV-GPCR interesting in terms of tumorigenesis. We reported that KSHV-GPCR exhibited marked constitutive, agonist-independent activity in mammalian cells (2). We also demonstrated that the constitutive activity of the viral GPCR could be inhibited by IP-10, acting as an inverse agonist (5). These results were later confirmed by Rosenkilde et al. (6). Last, we showed that signaling by KSHV-GPCR could be inhibited by GPCR-specific protein kinases and suggested that this may represent a form of homologous desensitization of this viral receptor (7). However, the effect of the constitutive activity of KSHV-GPCR on signaling by other receptors (heterologous desensitization) has not been previously investigated.To investigate the effect of constitutive signaling by KSHV-GPCR on other receptors that utilize the phosphoinositide/ calcium signaling pathway, we studied the behavior of this receptor in Xenopus oocytes and in mammalian cells. Our results show that KSHV-GPCR causes marked desensitization of responses mediated by TRH-Rs and m1-Rs by inhibiting InsP 3 -stimulated mobilization of Ca 2ϩ .
EXPERIMENTAL PROCEDURESXenopus laevis Oocytes-Defolliculated oocytes were obtained from mature Xenopus females, essentially as previously described (8). In vitro transcribed cRNAs for wild type TRH-Rs, m1-Rs (1 ng/oocyte), gastrin-releasing peptide (GRP) receptors (0.23 ng/oocyte), and KSHVGPCRs (1-3 ng/oocyte) were injected 48 h before the assay as described previously (9 -11).Electrophysiology-Two-electrode voltage clamp measurements wer...